Exane Derivatives’s Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock) ENIA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-641
Closed -$5.26K 698
2016
Q4
$5.26K Sell
641
-5,500
-90% -$45.8K ﹤0.01% 432
2016
Q3
$50.3K Sell
6,141
-15,410
-72% -$132K 0.01% 304
2016
Q2
$185K Sell
21,551
-60,945
-74% -$485K 0.03% 207
2016
Q1
$618K Sell
82,496
-30,198
-27% -$202K 0.08% 123
2015
Q4
$738K Buy
112,694
+2,898
+3% +$19.7K 0.1% 96
2015
Q3
$749K Buy
109,796
+109,015
+13,958% +$833K 0.09% 102
2015
Q2
$6.66K Hold
781
﹤0.01% 385
2015
Q1
$6.84K Sell
781
-5,330
-87% -$45.7K ﹤0.01% 394
2014
Q4
$52.8K Buy
+6,111
New +$52.4K 0.01% 320

Other funds holding ENIA

Exane Derivatives's ENIA Position: Q1 2017 in Review

Exane Derivatives sold out of Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock) (ENIA) in Q1 2017, closing a stake of 641 shares — an estimated $5.26K sold.

Exane Derivatives first reported a position in ENIA in Q4 2014 and held it in 9 quarters. The position peaked at $749K in Q3 2015. 140 funds tracked by Wall St. Rank hold ENIA as of Q1 2017.

  • Exane Derivatives reported no remaining Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock) position as of Q1 2017 after selling out during the quarter.
  • Exane Derivatives sold 641 Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock) shares in Q1 2017, an estimated $5.26K.
  • Exane Derivatives first reported a position in Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock) in Q4 2014 and held it in 9 quarters.
  • Exane Derivatives's Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock) position peaked at $749K in Q3 2015.
  • 140 funds tracked by Wall St. Rank held Enel Amricas S.A. American Depositary Shares (Each representing 50 shares of Common Stock) as of Q1 2017.

Based on Exane Derivatives's 13F filing for Q1 2017, filed 28 Apr 2017.